BLENREP FDA approval date

The FDA approved BLENREP on 23 Oct 2025.

FDA approval date
23 Oct 2025

Drug identity has not yet been verified against registry records

Also recorded as BELANTAMAB MAFODOTIN-BLMF

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-10-23DayBLENREPFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761440", "applicant_as_listed_by_fda": "GLAXOSMITHKLINE LLC", "brand_names": ["BLENREP"], "active_ingredients": ["BELANTAMAB MAFODOTIN-BLMF"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20251023", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026